The Kimberley Prospector

Day: February 25, 2026

GSK enters agreement to acquire 35Pharma Inc.

GSK enters agreement to acquire 35Pharma Inc.

Includes HS235, a potentially best-in-class activin signaling inhibitor in clinical development for treatment of cardiopulmonary diseases. Read more: GSK enters agreement to acquire 35Pharma Inc.

Back to top